Day: September 10, 2024

MILWAUKEE, Sept. 10, 2024 (GLOBE NEWSWIRE) — Brady Corporation (NYSE:BRC) (“Brady” or “Company”) announced that Deidre (Dee) Cusack has joined its Board of Directors, effective September 4, 2024. Ms. Cusack was Executive Vice President of Global Products & Solutions for Dematic, a manufacturer of intelligent automated solutions for manufacturing, warehouse, and distribution environments from 2020 until her retirement in 2024. Prior to Dematic, she spent 10 years at ABB in several business unit leadership roles, most recently as Group Senior Vice President & Global Product Group Manager of Distribution Transformers, and previously served in a variety of research and development and other leadership roles at Ametek and Raytheon Technologies Corp. Ms. Cusack received a Master of Science in Electrical Engineering from Tufts...

ATLANTA, Sept. 10, 2024 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the Deutsche Bank Annual Leveraged Finance Conference in Scottsdale, AZ on September 24, 2024. Management will host 1×1 investor meetings that day. About Aveanna HealthcareAveanna Healthcare is headquartered in Atlanta, Georgia and has locations in 33 states providing a broad range of pediatric and adult healthcare services including nursing, rehabilitation services, occupational nursing in schools, therapy services, day treatment centers for medically fragile and chronically ill children and adults, home health and hospice services, as well as delivery of enteral nutrition and other products to patients. The Company also provides case management services in order to assist...

Ms. Thompson Brings Nearly 25 Years of HR Leadership Driving Top Performing Cultures and Building Exceptional Teams CHASKA, Minn., Sept. 10, 2024 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced the appointment of Brikkelle Thompson as senior vice president of human resources. Ms. Thompson brings nearly 25 years of visionary human resources leadership, global experience, and deep talent management to Lifecore, including 14 years in the medical technology, medical device, and healthcare industries. She will be charged with enhancing the company’s performance-driven culture, while further strengthening the Lifecore team by maintaining and securing exceptional talent. “As we continue to sharpen...

RAMSEY, N.J. and BOCA RATON, Fla., Sept. 10, 2024 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, today announced Adam Grossman, President and Chief Executive Officer, will participate in a fireside chat at the 2024 Cantor Global Healthcare Conference in New York, NY on September 17, 2024, at 3:05 p.m. ET. A live audio webcast of the call will be available under “Events & Webcasts” in the investor section of the Company’s website, https://ir.admabiologics.com/events-webcasts. An archived webcast will be available on the Company’s website approximately two hours after the event. About ADMA Biologics, Inc. (ADMA) ADMA Biologics is an end-to-end commercial biopharmaceutical...

MONTREAL, Quebec, Sept. 10, 2024 (GLOBE NEWSWIRE) — Troilus Gold Corp. (“Troilus” or the “Company”, TSX: TLG; OTCQX: CHXMF; FSE: CM5R) is pleased to announce the appointment of Chantal Lavoie to its Board of Directors, effective immediately. Mr. Lavoie is a Professional Mining Engineer who brings over 35 years of experience in mining operations, permitting, construction, and executive leadership across various global mining regions, including Quebec. Chantal Lavoie, a native of Chicoutimi, Northern Quebec, has a distinguished career in both open-pit and underground mining, holding senior management and executive roles with some of the world’s largest mining companies, including Manager of Underground Division for Barrick’s Goldstrike Project as well as COO for De Beers’ Canadian mining operations during the construction of the...

WAYNE, Pa., Sept. 10, 2024 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that members of the Aclaris management team will participate in a fireside chat during the 2024 Cantor Global Healthcare Conference on Tuesday, September 17, 2024 at 8:00 AM ET in New York, New York. A webcast of the fireside chat may be accessed through the “Events” page of the “Investors” section of Aclaris’ website, www.aclaristx.com. The webcast will be archived for at least 30 days on the Aclaris website. About Aclaris Therapeutics, Inc. Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory...

TORONTO, Sept. 10, 2024 (GLOBE NEWSWIRE) — Lithium Ionic Corp. (TSXV: LTH; OTCQX: LTHCF; FSE: H3N) (“Lithium Ionic” or the “Company”) is pleased to announce important permitting milestones with the approval of the Final Exploration Reports (Relatório Final de Pesquisa – RFP) for its Bandeira and Outro Lado lithium properties by the Agência Nacional de Mineração (ANM), Brazil’s National Mining Agency. Following the ANM’s approval of these reports, the Company has successfully submitted the Mining Concession application and the Economic Viability Study (Plano de Aproveitamento Econômico – PAE) for the Bandeira property. The PAE provides a comprehensive assessment of the technical, economic, and environmental aspects of the mining project, detailing the efficient and responsible extraction of mineral resources. Achieving...

TFF-dry powder HA antigen vaccine candidates induced neutralizing antibody titers in ferrets against H1 and H3 influenza strains Ongoing funded work to assess additional influenza strains FORT WORTH, Texas, Sept. 10, 2024 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the “Company” or “TFF Pharmaceuticals”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, announces positive preclinical data advancing a multivalent universal influenza vaccine manufactured by TFF to protect against seasonal and pandemic viruses. The data were produced in collaboration with Dr. Ted Ross, Global Director of Vaccine Development at Cleveland Clinic. “These preliminary data suggest that the intranasal administration...